Subgroup net benefit reparameterizes net benefit by including baseline prevalence, allowing clinical prediction models to be compared across protected subgroups on a utility scale.
From Utilitarian to Rawlsian Designs for Algorithmic Fairness
1 Pith paper cite this work. Polarity classification is still indexing.
abstract
There is a lack of consensus within the literature as to how `fairness' of algorithmic systems can be measured, and different metrics can often be at odds. In this paper, we approach this task by drawing on the ethical frameworks of utilitarianism and John Rawls. Informally, these two theories of distributive justice measure the `good' as either a population's sum of utility, or worst-off outcomes, respectively. We present a parameterized class of objective functions that interpolates between these two (possibly) conflicting notions of the `good'. This class is shown to represent a relaxation of the Rawlsian `veil of ignorance', and its sequence of optimal solutions converges to both a utilitarian and Rawlsian optimum. Several other properties of this class are studied, including: 1) a relationship to regularized optimization, 2) feasibility of consistent estimation, and 3) algorithmic cost. In several real-world datasets, we compute optimal solutions and construct the tradeoff between utilitarian and Rawlsian notions of the `good'. Empirically, we demonstrate that increasing model complexity can manifest strict improvements to both measures of the `good'. This work suggests that the proper degree of `fairness' can be informed by a designer's preferences over the space of induced utilitarian and Rawlsian `good'.
fields
stat.AP 1years
2024 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Understanding algorithmic fairness for clinical prediction in terms of subgroup net benefit and health equity
Subgroup net benefit reparameterizes net benefit by including baseline prevalence, allowing clinical prediction models to be compared across protected subgroups on a utility scale.